Skip to main content

Table 2 Significant differences of physical function and health-related quality of life between levels of disease activity (SDAI) in early (≤2 years) and late rheumatoid arthritis patients

From: Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs

  HAQ SF-6D EQ-5D SF-36 PCS
EARLY RA
REM (n = 7) 0.14 ± 0.2 0.74 ± 0.15 0.92 ± 0.10 42.7 ± 11.7
LDA (n = 26) 0.39 ± 0.42 0.70 ± 0.15 0.81 ± 0.16 41.8 ± 7.1
MDA/HDA (n = 25) 1.05 ± 0.81 0.60 ± 0.13 0.71 ± 0.19 33.1 ± 9.8
P Value <0.01 0.01 0.01 0.006
LATE RA
REM (n = 80) 0.41 ± 0.59 0.75 ± 0.15 0.89 ± 0.12 46.3 ± 8.3
LDA (n = 124) 0.78 ± 0.71 0.65 ± 0.14 0.77 ± 0.16 37.6 ± 10.9
MDA/HDA (n = 94) 1.30 ± 0.72 0.57 ± 0.11 0.65 ± 0.22 28.9 ± 8.8
P Value <0.01 <0.01 <0.01 <0.01
  1. EQ-5D, Euro Quality of life 5 dimensions; HAQ, Health Assessment Questionnaire; LDA, low disease activity; MDA/HDA moderate disease activity/high disease activity; RA, rheumatoid arthritis; REM, remission; SF-6D, Short Form 6 dimensions; SF-36 PCS, Short Form 36 Physical Component Score.